Ivor Royston

Companies

• Viracta Therapeutics, Inc.Board member Feb 24, 2021 to Nov 27, 2024¹
• BIOCEPT INCBoard member Feb 4, 2014 to Sep 8, 2022²
• Viracta Therapeutics, Inc.Chief executive officer Feb 24, 2021 to Aug 29, 2022¹
• Viracta Therapeutics, Inc.President Feb 24, 2021 to Aug 29, 2022¹
• Syndax Pharmaceuticals IncBoard member Mar 2, 2016 to Mar 22, 2017³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• VTViracta Therapeutics, Inc.858,340 shares⁴Nov 27, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Nov 25, 2024Exercised options 25,219 shares of Viracta Therapeutics, Inc.⁴
• Aug 25, 2024Exercised options 25,219 shares of Viracta Therapeutics, Inc.⁵
• May 25, 2024Exercised options 25,219 shares of Viracta Therapeutics, Inc.⁶
• Feb 25, 2024Exercised options 25,219 shares of Viracta Therapeutics, Inc.⁷
• Nov 25, 2023Exercised options 25,219 shares of Viracta Therapeutics, Inc.⁸
• Aug 25, 2023Exercised options 25,219 shares of Viracta Therapeutics, Inc.⁹
• May 25, 2023Exercised options 25,219 shares of Viracta Therapeutics, Inc.¹⁰
• Feb 25, 2023Exercised options 25,219 shares of Viracta Therapeutics, Inc.¹¹
• Nov 25, 2022Exercised options 25,219 shares of Viracta Therapeutics, Inc.¹²
• Aug 26, 2022Sold 13,379 shares at $4.01 of Viracta Therapeutics, Inc.¹³
• Aug 25, 2022Exercised options 25,219 shares of Viracta Therapeutics, Inc.¹³
• May 26, 2022Sold 13,162 shares at $1.90 of Viracta Therapeutics, Inc.¹⁴
• May 25, 2022Exercised options 25,219 shares of Viracta Therapeutics, Inc.¹⁴
• Feb 28, 2022Sold 14,635 shares at $2.78 of Viracta Therapeutics, Inc.¹⁵
• Feb 25, 2022Exercised options 25,219 shares of Viracta Therapeutics, Inc.¹⁵
• Dec 29, 2021Exercised options 7,000 shares at $0.90 of Viracta Therapeutics, Inc.¹⁶
• Nov 29, 2021Sold 15,833 shares at $4.82 of Viracta Therapeutics, Inc.¹⁷
• Nov 26, 2021Sold 11,914 shares at $4.80 of Viracta Therapeutics, Inc.¹⁷
• Nov 25, 2021Exercised options 50,437 shares of Viracta Therapeutics, Inc.¹⁷
• Nov 15, 2021Bought 8,000 shares at $5.56 of Viracta Therapeutics, Inc.¹⁸